TNNI3 and cardiovascular disorder: In conclusion, our findings show that in patients with long-lasting type 2 diabetes that are intensively treated with insulin, the concomitant use of metformin does not affect circulating cardiac troponin I and T as compared to placebo when tested in a trial cohort that previously reported reduction in cardiovascular disease associated with the drug.